+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proteomics discovery of biomarkers in statin-treated patients with advanced coronary artery disease



Proteomics discovery of biomarkers in statin-treated patients with advanced coronary artery disease



Atherosclerosis 263: E241-E241




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065445136

Download citation: RISBibTeXText

PMID: 29365926

DOI: 10.1016/j.atherosclerosis.2017.06.783


Related references

Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia. Journal of Clinical Lipidology 11(3): 682-693, 2017

Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study). American Journal of Cardiology 118(4): 494-498, 2017

The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease. Inflammation Research 60(3): 281-287, 2011

Vitamin D status was not associated with 'one-year' progression of coronary artery disease, assessed by coronary angiography in statin-treated patients. European Journal of Preventive Cardiology 22(5): 594-602, 2016

Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease. American Journal of Cardiology 111(1): 6-11, 2013

Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention. Journal of Atherosclerosis and Thrombosis 24(11): 1125-1131, 2017

Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy. Cardiovascular Revascularization Medicine 15(3): 131-136, 2014

Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China. International Journal of Cardiology 182: 469-475, 2015

Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circulation Journal 73(7): 1283-1290, 2009

Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol in statin-treated patients with coronary artery disease. 2007

Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease. Heart 104(20): 1699-1705, 2018

Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin. Thrombosis and Haemostasis 112(2): 323-331, 2015

Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease. Wiener Klinische Wochenschrift 119(15-16): 476-482, 2007

Association of LDL phenotypes with cholesterol synthesis and HDL subclasses in statin-treated coronary artery disease patients and healthy subjects. Atherosclerosis 263: E205-E205, 2018

The apolipoprotein B/A1 ratio is associated with reactive oxygen metabolites and endothelial dysfunction in statin-treated patients with coronary artery disease. Journal of Atherosclerosis and Thrombosis 20(7): 623-629, 2014